Comparison of different treatment approaches of pediatric chronic non-bacterial osteomyelitis

被引:0
|
作者
Mikhail M. Kostik
Olga L. Kopchak
Irina A. Chikova
Eugenia A. Isupova
Alexander Y. Mushkin
机构
[1] Saint-Petersburg State Pediatric Medical University,
[2] Kirov’s Regional Children’s Hospital,undefined
[3] Science Research Institute of Phthisiopulmonology,undefined
来源
Rheumatology International | 2019年 / 39卷
关键词
Chronic non-bacterial osteomyelitis; Pamidronate; TNFα-inhibitors;
D O I
暂无
中图分类号
学科分类号
摘要
Chronic non-bacterial osteomyelitis (CNO) is a chronic inflammatory bone disease which usually manifests in children and adolescents. There are a few data about pathogenesis and treatment. The aim of the study to compare the efficacy of different treatment approaches in pediatric CNO cohort patient. Fifty two children (25 boys and 27 girls) with CNO with average age at the onset of the disease 8.4 years (5.4; 11.0), number of foci − 3.0 (2.0; 6.0, incl. multifocal cases in 80.8%). Non-steroid anti-inflammatory drugs (NSAID) was the first-line treatment for non-vertebral cases, as well as pamidronate (PAM) for vertebral involvement. Second-line treatment includes sulfasalazine (SSZ), methotrexate (MTX), PAM and tumor necrosis factor-α inhibitors (TNFα-inh). We evaluated the dynamics of pain, patient’s and physician’s (MDVAS) assessment with visual-analog scale (VAS) and ability to each medication to achieve remission of CNO activity. According to the NSAID, MTX, SSZ, PAM and TNFα-inh groups the following data were registered: patient’s VAS: − 14.2% (p = 0.05), − 50.0% (p = 0.04), − 23.1 (p = 0.89), − 83.3% (p = 0.0001), − 73.6% (p = 0.0007); painVAS: − 21.9% (p = 0.01), − 18.6% (p = 0.13), + 36.4 (p = 0.89), − 79.7% (p = 0.00016), − 74.1%, (p = 0.0015); MDVAS: − 13.8% (p = 0.13); − 56.4% (p = 0.09), + 30.8% (p = 0.89), − 74.7%, (p = 0.0001), − 82.1 (p = 0.0015) respectively. The ability of each treatment strategy to achieve the CNO remission was 52.6%, 44.4%, 57,1%, 88.8% and 73.3%, respectively (log-rank test, p = 0.001). The efficacy of treatment approaches for CNO depended on the severity of the disease. NSAID, methotrexate, and sulfasalazine were effective in forms without spine involvement, but pamidronate and TNF-a inhibitors were useful in vertebral forms of CNO. Pamidronate and TNF-a inhibitors more extensively suppressed CNO activity. The randomized controlled trials for assessment of the efficacy and safety of these medications is mandatory to confirm these results.
引用
收藏
页码:89 / 96
页数:7
相关论文
共 50 条
  • [31] Oral administration of alendronate and vitamin D3 for the treatment of chronic non-bacterial osteomyelitis of the jaw
    Yang, X.
    Zhou, K.
    Shang, W.
    Song, K.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2020, 49 (12) : 1595 - 1598
  • [32] A standardised clinical and radiological follow-up of patients with chronic non-bacterial osteomyelitis treated with pamidronate
    Hofmann, C.
    Wurm, M.
    Schwarz, T.
    Neubauer, H.
    Beer, M.
    Girschick, H.
    Morbach, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : 604 - 609
  • [33] Successful treatment of erythema nodosum with salazosulfapyridine in a 9-year-old patient with chronic non-bacterial osteomyelitis
    Shimomura, Masaki
    Okura, Yuka
    Takahashi, Yutaka
    Kobayashi, Ichiro
    MODERN RHEUMATOLOGY CASE REPORTS, 2024, 8 (02) : 394 - 397
  • [34] Physical activity and health-related quality of life in chronic non-bacterial osteomyelitis
    Nentwich Julia
    Ruf Katharina
    Girschick Hermann
    Holl-Wieden Annette
    Morbach Henner
    Hebestreit Helge
    Hofmann Christine
    Pediatric Rheumatology, 17
  • [35] Physical activity and health-related quality of life in chronic non-bacterial osteomyelitis
    Julia, Nentwich
    Katharina, Ruf
    Hermann, Girschick
    Annette, Holl-Wieden
    Henner, Morbach
    Helge, Hebestreit
    Christine, Hofmann
    PEDIATRIC RHEUMATOLOGY, 2019, 17
  • [36] Reconstructive surgery with an autologous bone graft in a dog with presumptive chronic non-bacterial osteomyelitis
    Jung, Jae-Hwan
    Han, Hyun-Jung
    Yoon, Hun-Young
    VETERINARY MEDICINE AND SCIENCE, 2024, 10 (02)
  • [37] Spinal Involvement in Patients with Chronic Non-Bacterial Osteomyelitis (CNO): An Analysis of Distinctive Imaging Features
    Byrdy-Daca, Marta
    Duczkowski, Marek
    Sudol-Szopinska, Iwona
    Zelewska, Marta
    Pilat, Krzysztof
    Daca, Filip
    Nieciecki, Michal
    Sztwiertnia, Pawel
    Walecki, Jerzy
    Cieszanowski, Andrzej
    Swiatkowski, Jan
    Berezniak, Marlena
    Sulkowska, Katarzyna
    Czubak, Jaroslaw
    Golebiowski, Marek
    Palczewski, Piotr
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (23)
  • [38] Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate
    Andreasen, C. M.
    Klicman, R. F.
    Herlin, T.
    Hauge, E. M.
    Jurik, A. G.
    PEDIATRIC RHEUMATOLOGY, 2022, 20 (01)
  • [39] Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate
    C. M. Andreasen
    R. F. Klicman
    T. Herlin
    E. M. Hauge
    A. G. Jurik
    Pediatric Rheumatology, 20
  • [40] Association of chronic non-bacterial osteomyelitis with Crohn’s disease but not with CARD15 gene variants
    Henner Morbach
    Anke Dick
    Christine Beck
    Martin Stenzel
    Hans Konrad Müller-Hermelink
    Peter Raab
    Hemann Josef Girschick
    Rheumatology International, 2010, 30 : 617 - 621